US pharmaceutical giant Johnson & Johnson will "exit from the opioid business nationally" as part of a $230 million settlement with New York, the state's attorney general Letitia James said Saturday. The agreement allows Johnson & Johnson to resolve litigation over its "role in helping to fuel the opioid epidemic," according to a statement from the prosecutor, who said the company would spread the payments over nine years. bur-dt/st/bbk